Revvity Inc (RVTY)
101.86
+1.25
(+1.24%)
USD |
NYSE |
May 06, 11:32
Revvity Cash from Financing (Quarterly): -35.01M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.01M |
| December 31, 2023 | -19.61M |
| September 30, 2023 | -586.05M |
| June 30, 2023 | -228.27M |
| March 31, 2023 | -113.18M |
| December 31, 2022 | -76.70M |
| September 30, 2022 | -65.64M |
| June 30, 2022 | -354.61M |
| March 31, 2022 | -164.86M |
| December 31, 2021 | -139.02M |
| September 30, 2021 | 2.755B |
| June 30, 2021 | -257.72M |
| March 31, 2021 | 582.99M |
| December 31, 2020 | 73.43M |
| September 30, 2020 | -155.94M |
| June 30, 2020 | -95.77M |
| March 31, 2020 | -24.59M |
| December 31, 2019 | -251.20M |
| September 30, 2019 | 170.13M |
| June 30, 2019 | 225.96M |
| March 31, 2019 | 5.235M |
| December 31, 2018 | -57.27M |
| September 30, 2018 | -109.03M |
| June 30, 2018 | -25.94M |
| March 31, 2018 | 13.01M |
| Date | Value |
|---|---|
| December 31, 2017 | 816.69M |
| September 30, 2017 | -15.68M |
| June 30, 2017 | -2.586M |
| March 31, 2017 | -16.18M |
| December 31, 2016 | -62.37M |
| September 30, 2016 | 59.80M |
| June 30, 2016 | -64.74M |
| March 31, 2016 | -47.70M |
| December 31, 2015 | -14.71M |
| September 30, 2015 | -44.02M |
| June 30, 2015 | -23.72M |
| March 31, 2015 | -24.69M |
| December 31, 2014 | 154.63M |
| September 30, 2014 | -47.01M |
| June 30, 2014 | -65.14M |
| March 31, 2014 | -11.55M |
| December 31, 2013 | -15.43M |
| September 30, 2013 | -67.76M |
| June 30, 2013 | -28.38M |
| March 31, 2013 | -42.59M |
| December 31, 2012 | 12.11M |
| September 30, 2012 | -7.446M |
| June 30, 2012 | -38.63M |
| March 31, 2012 | -10.20M |
| December 31, 2011 | 419.50M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-586.05M
Minimum
Sep 2023
2.755B
Maximum
Sep 2021
61.99M
Average
-86.24M
Median
Cash from Financing (Quarterly) Benchmarks
| Agilent Technologies Inc | -240.00M |
| Bruker Corp | 151.70M |
| Azenta Inc | -113.15M |
| Harvard Bioscience Inc | -4.116M |
| Bionano Genomics Inc | 68.48M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 147.56M |
| Cash from Investing (Quarterly) | -18.18M |
| Free Cash Flow | 97.11M |
| Free Cash Flow Per Share (Quarterly) | 1.05 |
| Free Cash Flow to Equity (Quarterly) | 152.92M |
| Free Cash Flow to Firm (Quarterly) | 133.30M |
| Free Cash Flow Yield | 0.77% |